Argent Biopharma Limited has released a press release.
Appendix 4E and Audited 2017 Financial Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- RMIT and MGC Pharmaceuticals Sign Strategic Agreement
- Botanical Division Update - Europe and Australia
- First European Distribution Deal Signed for API Products
- EU Medical Cannabis License Granted with Strategic Agreement
- Positive MGC Derma Clinical Test Results
Later from Argent Biopharma
- Major EU Pharma Supply Agreement Signed with Lenis
- MXC Botanic Division Operational Update
- $40 Million White-Label CBD Cosmetics Agreement Executed
- First $8m Binding Cosmetics Sales Agreement Signed
- MXC Enters Multi $M Australian Pharma Market
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma